ENTITY
Vectura

Vectura (VEC LN)

7
Analysis
Health CareUnited Kingdom
Vectura Group PLC develops inhaled therapies for the treatment of respiratory diseases. The Company's main products are used to treat asthma and chronic obstructive pulmonary disease. Vectura also develops products for lung pathologies and non-respiratory diseases.
more
News Icon
No news found
We’ll display news we find for Vectura here
x